Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc CRDL


Primary Symbol: T.CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > News Financial Interview with Elsley
View:
Post by Youhillman on Mar 26, 2021 11:32am

News Financial Interview with Elsley

Interview today with Elsley.

The interview covers a number of areas.

To me what's most exciting is the pending NASDAQ listing, what's most disappointing is the update on Cortalex sales and how they will do a marketing ramp up later this year. Really the product has been for sale now for 5+ months and you will focus on it later this year, that's like a 12 month ramp up, very disappointing for current shareholders.

To me it's reads that they are so focused on Covid and AM trials that Cortalex is almost an afterthought.

Still, I'm long on CRDL, they will be a Billion Dollar company, so I see their shares trading between $30-50 within the next year.

Enjoy the read....

https://news.financial/interviews/interview-with-cardiol-therapeutics-how-the-heart-disease-specialist-company-plans-to-take-off-on-the-nasdaq-in-2021
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities